Results 241 to 250 of about 386,415 (318)
Pathologic Analysis of Pulmonary Interstitial Fibrosis [PDF]
Jin‐Suck Suh, Eui Keun Ham
openalex +1 more source
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu+9 more
wiley +1 more source
Nutritional insights into pulmonary fibrosis: a comprehensive review on the impact of vitamins. [PDF]
Qu Y, Zhao Y.
europepmc +1 more source
Diagnosis of early idiopathic pulmonary fibrosis: current status and future perspective. [PDF]
Wang X+6 more
europepmc +1 more source
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr+15 more
wiley +1 more source
Predictive models and WTAP targeting for idiopathic pulmonary fibrosis (IPF). [PDF]
Li GD+5 more
europepmc +1 more source
Abstract Right ventricular failure (RVF) is a common complication following left ventricular assist device (LVAD) implantation and increases patient morbidity and mortality. Due to the complex and limited understanding of RVF pathophysiology, efforts to prognosticate RVF after LVAD have been challenging.
Abdul‐Fatawu Osman+11 more
wiley +1 more source
Inhalable Hsa-miR-30a-3p Liposomes Attenuate Pulmonary Fibrosis. [PDF]
Liu S+14 more
europepmc +1 more source
Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP [PDF]
Shuntaro Nagai+5 more
openalex +1 more source